Patients diagnosed with acquired (autoimmune) hemophilia, a serious and rare bleeding disorder, have high rates of hospital ...

Researchers from the Centenary Institute have uncovered a reason why some people with hemophilia A develop resistance to ...

Genentech’s short film draws on the experiences of multiple families caring for children with hemophilia A, seeking to ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

Although less common than hemophilia or von Willebrand disease, inherited rare bleeding disorders, comprising afibrinogenemia and deficiencies in factors II, V, VII, X, XI, XIII or V plus VIII ...

Asia Pacific’s Market Growth: The Asia Pacific region is anticipated to experience significant growth in the bleeding disorder testing market, with a projected CAGR of 6.5% from 2023 to 2033. This is ...

Columnist G Shellye Horowitz argues for a new way of classifying hemophilia severity that takes both genotype and phenotype into account.

A man’s acquired hemophilia coincided with a rare liver disease, a connection that had not been reported before, per a case ...

The approval in previously treated pediatric patients was based on data from the Alfa-PROTECT and PROTECT Kids studies.

MHH haematologists successfully treat seriously ill patients with acquired haemophilia A with CAR-T cells.

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients.